Incorporating the MolecuLight i:X into standard care helps clinicians identify fluorescent bacteria and facilitates evidence-based clinician decision making which has been shown to lead to:
What difference does MolecuLight i:X make?
MolecuLight i:X guided treatment increased the rate of wound healing (statistically significant) compared with standard care.
Up to 9X faster healing1
Incorporating the MolecuLight i:X into standard care helps clinicians identify and treat fluorescent bacteria which has been shown to reduce the average closure time of chronic wounds from 200 to 22 days (9X improvement over standard care).
Up to 89% overall reduction in cost when compared to standard care1
Being able to visualize the presence of bacteria in a wound can also help clinicians decide on a more cost-effective course of action. They might conclude that a simple, traditional dressing – not an antimicrobial dressing – is the best solution. A smaller stockpile of advanced dressings means more money saved. If advanced treatments are chosen, the MolecuLight i:X assists clinicians in removing bacteria prior to the application of these treatments to optimize the therapy.